The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
Abstract
Small colony variants constitute a slow-growing subpopulation of bacteria with distinctive phenotypic and pathogenic traits. Phenotypically, small colony variants have a slow growth rate, atypical colony morphology and unusual biochemical characteristics, making them a challenge for clinical microbiologists to identify. Clinically, small colony variants are better able to persist in mammalian cells and are less susceptible to antibiotics than their wild-type counterparts, and can cause latent or recurrent infections on emergence from the protective environment of the host cell. This Review covers the phenotypic, genetic and clinical picture associated with small colony variants, with an emphasis on staphylococci, for which the greatest amount of information is available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Staphylococcus aureus is a frequent cause of chronic and recurrent infections, which often involve the emergence of slow-growing mutants known as small-colony variants (SCVs) (1–14).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“SCVs with mutations in heme or menaquinone biosynthetic pathways have defective electron-transport chains, which confers resistance to aminoglycoside antibiotics such as gentamicin (1, 6, 8, 9).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“In addition to aminoglycoside resistance, SCVs that arise via the loss of the electron transport chain are more tolerant than wild-type bacteria of other classes of bactericidal antibiotics (8, 9, 25–29).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
In the citing paper
“Despite the importance of these defenses for wild-type S. aureus survival in the host, SCVs have been reported to produce significantly reduced levels of staphyloxanthin and heme auxotrophs are deficient in catalase, which would be expected to make them more susceptible to ROS generated by neutrophils and thus clearance from host tissues (9, 19, 28, 36, 45).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [9]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Sinha, B., Francois, P. P., Nusse, O., Foti, M., Hartford, O. M., Vaudaux, P., Foster, T. J., Lew, D. P., Herrmann, M., & Krause, K.-H. (1999) · Cellular Microbiology · doi:10.1046/j.1462-5822.1999.00011.x · Cited by 563
Self-citationInfections Associated with Indwelling Medical Devices
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-391_2 · Cited by 537
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
Self-citationKahl, B., Herrmann, M., Everding, A. S., Koch, H. G., Becker, K., Harms, E., Proctor, R. A., & Peters, G. (1998) · Journal of Infectious Diseases · doi:10.1086/515238 · Cited by 357
Self-citationIntracellular Staphylococcus aureus Escapes the Endosome and Induces Apoptosis in Epithelial Cells
Bayles, K. W., Wesson, C. A., Liou, L. E., Fox, L. K., Bohach, G. A., & Trumble, W. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.1.336-342.1998 · Cited by 349 · cited 1×
“aureus is not only an extracellular pathogen but also an intracellular pathogen, owing to effective uptake of these bacteria by non-professional phagocytes, such as endothelial and epithelial cells, fibroblasts, osteoblasts and keratinocyte”
Backgroundvon Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310
Self-citationDziewanowska, K., Patti, J. M., Deobald, C. F., Bayles, K. W., Trumble, W. R., & Bohach, G. A. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4673-4678.1999 · Cited by 297 · cited 1×
“SCV internalization is mediated by fibronectin bridging between the bacterial fibronectin-binding proteins (FnBPs) and the receptor α 5 β 1 -integrin, which is present at the surface of eukaryotic cell”
Backgroundvon Eiff, C., Bettin, D., Proctor, R. A., Rolauffs, B., Lindner, N., Winkelmann, W., & Peters, G. (1997) · Clinical Infectious Diseases · doi:10.1086/516962 · Cited by 247
Self-citationSmall-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Research works printed but not linked: 8
- Jacobsen, K. A. Mitteilungen über einen variablen Typhusstamm (Bacterium typhi mutabile), sowie über eine eigentümliche hemmende Wirkung des gewöhnlichen agar, verursacht durch autoklavierung. Zentralbl. Bakteriol. [Orig. A] 56, 208–216 (1910) (in German).
- Borderon, E. & Horodniceanu, T. Mutants déficients a colonies naines de Staphylococcus: ètude de trois souches isolées chez des malades porteurs d'osteosyntheses. Ann. Microbiol. (Paris) 127, 503–514 (1976) (in French).
- Thomas, M. E. M. & Cowlard, J. H. Studies on a CO2-dependent Staphylococcus. J. Clin. Pathol. 8, 288–291 (1955). · DOI
- Slifkin, M., Merkow, L. P., Kreuzberger, S. A., Engwall, C. & Pardo, M. Characterization of CO2 dependent microcolony variants of Staphylococcus aureus. Am. J. Clin. Pathol. 56, 584–592 (1971). · DOI
- Stryer, L. in Biochemistry 739–762 (Freeman and Company, New York, 1995).
- Salgado, D. R., Boza, F. A., Pinto, M. & Sampaio, J. Outbreak with small colony variants of methicillin-resistant Staphylococcus aureus in an ICU. Abstract K-1226. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago, Illinois, USA, 16–19 Dec 2001).
- Häussler, S., Tummler, B., Weissbrodt, H., Rohde, M. & Steinmetz, I. Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. Clin. Infect. Dis. 29, 621–625 (1999). · DOI · Paper page
- Borderon, E., Horodniceanu, T., Buissiere, J. & Barthez, J. P. Mutants déficients à colonies naines de Escherichia coli: ètude d'une souche thiamine-déficiente isolée d'une uroculture. Ann. Microbiol. (Paris) 128A, 413–417 (1977) (in French).
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
“, possibly because they can persist intracellularly, shielded from the host immune respons”
BackgroundImplant infections: adhesion, biofilm formation and immune evasion
Arciola, C. R., Campoccia, D., & Montanaro, L. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0019-y · Cited by 2,241
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Self-citationPathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Rumbaugh, K. P., & Sauer, K. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0385-0 · Cited by 907
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Insights into the mode of action of chitosan as an antibacterial compound.
Raafat, D., von Bargen, K., Haas, A., & Sahl, H.-G. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.00453-08 · Cited by 888
Antibiotic resistance and persistence—implications for human health and treatment perspectives
Huemer, M., Mairpady Shambat, S., Brugger, S. D., & Zinkernagel, A. S. (2020) · The EMBO Reports · doi:10.15252/embr.202051034 · Cited by 850
“Usually, nsSCs are defined as colonies with an area 5 or 10 times smaller than the area of the most common colony type (Proctor et al , 2006).”
InfluentialThe Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Staphylococcus aureus host interactions and adaptation
Howden, B. P., Giulieri, S. G., Wong Fok Lung, T., Baines, S. L., Sharkey, L. K., Lee, J. Y. H., Hachani, A., Monk, I. R., & Stinear, T. P. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00852-y · Cited by 689
Skeletal infections: microbial pathogenesis, immunity and clinical management
Masters, E. A., Ricciardi, B. F., Bentley, K. L. D. M., Moriarty, T. F., Schwarz, E. M., & Muthukrishnan, G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00686-0 · Cited by 735
Mechanisms of Cyclic-di-GMP Signaling in Bacteria
Jenal, U., & Malone, J. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090423 · Cited by 647
Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions
Kavanagh, N., Ryan, E. J., Widaa, A., Sexton, G., Fennell, J., O'Rourke, S., Cahill, K. C., Kearney, C. J., O'Brien, F. J., & Kerrigan, S. W. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-17 · Cited by 547
Antibiotic Resistance and the MRSA Problem
Vestergaard, M., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 490
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
Hoffman, L. R., Déziel, E., D'Argenio, D. A., Lépine, F., Emerson, J., McNamara, S., Gibson, R. L., Ramsey, B. W., & Miller, S. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606756104 · Cited by 467
Staphylococcus aureus: new evidence for intracellular persistence
Garzoni, C., & Kelley, W. L. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.005 · Cited by 474
Kubica, M., Guzik, K., Koziel, J., Zarebski, M., Richter, W., Gajkowska, B., Golda, A., Maciag-Gudowska, A., Brix, K., Shaw, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001409 · Cited by 457
Evolution of high-level resistance during low-level antibiotic exposure
Wistrand-Yuen, E., Knopp, M., Hjort, K., Koskiniemi, S., Berg, O. G., & Andersson, D. I. (2018) · Nature Communications · doi:10.1038/s41467-018-04059-1 · Cited by 466
Bacterial and Fungal Biofilm Infections
Lynch, A. S., & Robertson, G. T. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.110106.132000 · Cited by 447
Peptide Signaling in the Staphylococci
Thoendel, M., Kavanaugh, J. S., Flack, C. E., & Horswill, A. R. (2011) · Chemical Reviews · doi:10.1021/cr100370n · Cited by 438
Plant Antimicrobial Agents and Their Effects on Plant and Human Pathogens
González-Lamothe, R., Mitchell, G., Gattuso, M., Diarra, M. S., Malouin, F., & Bouarab, K. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10083400 · Cited by 413
Tuchscherr, L., Medina, E., Hussain, M., Völker, W., Heitmann, V., Niemann, S., Holzinger, D., Roth, J., Proctor, R. A., Becker, K., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201000115 · Cited by 437
Self-citationClinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update
Saiman, L., Siegel, J. D., LiPuma, J. J., Brown, R. F., Bryson, E. A., Chambers, M. J., Downer, V. S., Fliege, J., Hazle, L. A., Jain, M., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676882 · Cited by 387
Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy
Hussain, S., Joo, J., Kang, J., Kim, B., Braun, G. B., She, Z.-G., Kim, D., Mann, A. P., Mölder, T., Teesalu, T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0187-5 · Cited by 399
Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides
Lázár, V., Martins, A., Spohn, R., Daruka, L., Grézal, G., Fekete, G., Számel, M., Jangir, P. K., Kintses, B., Csörgő, B., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0164-0 · Cited by 375
Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response
Grant, S. S., & Hung, D. T. (2013) · Virulence · doi:10.4161/viru.23987 · Cited by 363
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
Abed, N., & Couvreur, P. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.02.009 · Cited by 358
Lipase-Sensitive Polymeric Triple-Layered Nanogel for “On-Demand” Drug Delivery
Xiong, M.-H., Bao, Y., Yang, X.-Z., Wang, Y.-C., Sun, B., & Wang, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211279u · Cited by 361
A global view of antibiotic resistance
Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martínez-Solano, L., & Sánchez, M. B. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00142.x · Cited by 356
Bacterial persisters: molecular mechanisms and therapeutic development
Niu, H., Gu, J., & Zhang, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01866-5 · Cited by 310
“109,117,118 These small colonies represent a subpopulation of persister cells with an extended bacterial lag phase, 119 and their frequency within a bacterial population tends to increase following exposure to stressors such as acidic pH 120 or reactive oxygen species.”
BackgroundBacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Heme Synthesis and Acquisition in Bacterial Pathogens
Choby, J. E., & Skaar, E. P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.018 · Cited by 343
Mimicking biofilm formation and development: Recent progress in in vitro and in vivo biofilm models
Guzmán-Soto, I., McTiernan, C., Gonzalez-Gomez, M., Ross, A., Gupta, K., Suuronen, E. J., Mah, T.-F., Griffith, M., & Alarcon, E. I. (2021) · iScience · doi:10.1016/j.isci.2021.102443 · Cited by 309
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Self-citationAre coagulase-negative staphylococci virulent?
Heilmann, C., Ziebuhr, W., & Becker, K. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.11.012 · Cited by 298
Self-citationPfaller, M. A., Andes, D., Diekema, D. J., Espinel-Ingroff, A., & Sheehan, D. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.09.002 · Cited by 314
The distribution of bacterial doubling times in the wild
Gibson, B., Wilson, D. J., Feil, E., & Eyre-Walker, A. (2018) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2018.0789 · Cited by 288
Metabolic regulation of antibiotic resistance
Martínez, J. L., & Rojo, F. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00282.x · Cited by 304
Bacteria‐Responsive Multifunctional Nanogel for Targeted Antibiotic Delivery
Xiong, M., Li, Y., Bao, Y., Yang, X., Hu, B., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202847 · Cited by 299
Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis
Josse, J., Velard, F., & Gangloff, S. C. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00085 · Cited by 286
“SCVs consist of higher capacities for intracellular persistence and are less liable to antibiotics than their wild-type counterparts (Proctor et al., 2006).”
BackgroundSousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00106 · Cited by 289
Staphylococcus aureus as an intracellular pathogen: the role of small colony variants
Sendi, P., & Proctor, R. A. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.004 · Cited by 279
Self-citationMechanisms of infective endocarditis: pathogen–host interaction and risk states
Werdan, K., Dietz, S., Löffler, B., Niemann, S., Bushnaq, H., Silber, R.-E., Peters, G., & Müller-Werdan, U. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.174 · Cited by 283
Self-citationStaphylococcus aureus Small‐Colony Variants Are Adapted Phenotypes for Intracellular Persistence
Tuchscherr, L., Heitmann, V., Hussain, M., Viemann, D., Roth, J., von Eiff, C., Peters, G., Becker, K., & Löffler, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656047 · Cited by 275
Self-citationInteraction of staphylococci with bone
Wright, J. A., & Nair, S. P. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.10.003 · Cited by 255
Singh, R., Ray, P., Das, A., & Sharma, M. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009720-0 · Cited by 262
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane
Hamamoto, H., Urai, M., Ishii, K., Yasukawa, J., Paudel, A., Murai, M., Kaji, T., Kuranaga, T., Hamase, K., Katsu, T., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1710 · Cited by 263
Transport and Fate of Microbial Pathogens in Agricultural Settings
Bradford, S. A., Morales, V. L., Zhang, W., Harvey, R. W., Packman, A. I., Mohanram, A., & Welty, C. (2013) · Critical Reviews in Environmental Science and Technology · doi:10.1080/10643389.2012.710449 · Cited by 251
Gassiep, I., Armstrong, M., & Norton, R. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-19 · Cited by 246
“pseudomallei exhibits small-colony variants (SCVs) with unique phenotypic and pathological features (431, 432).”
BackgroundPlata, K., Rosato, A. E., & Wegrzyn, G. (2009) · Acta Biochimica Polonica · doi:10.18388/abp.2009_2491 · Cited by 259
Proctor, R. A., Kriegeskorte, A., Kahl, B. C., Becker, K., Löffler, B., & Peters, G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00099 · Cited by 237
Self-citationStaphylococcal response to oxidative stress
Gaupp, R., Ledala, N., & Somerville, G. A. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00033 · Cited by 253
“SCVs are often associated with persistent and recurrent infections and are characterized by numerous phenotypic changes (Proctor et al., 2006).”
BackgroundLázár, V., Nagy, I., Spohn, R., Csörgő, B., Györkei, Á., Nyerges, Á., Horváth, B., Vörös, A., Busa-Fekete, R., Hrtyan, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5352 · Cited by 249
Kingella kingae: Carriage, Transmission, and Disease
Yagupsky, P. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-14 · Cited by 239
Osteomyelitis: Recent advances in pathophysiology and therapeutic strategies
Birt, M. C., Anderson, D. W., Bruce Toby, E., & Wang, J. (2017) · Journal of Orthopaedics · doi:10.1016/j.jor.2016.10.004 · Cited by 238
Pathogenesis of implant-associated infection: the role of the host
Zimmerli, W., & Sendi, P. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0275-7 · Cited by 226
Orazi, G., & O’Toole, G. A. (2017) · mBio · doi:10.1128/mbio.00873-17 · Cited by 220
Staphylococcus aureus Small Colony Variants in Prosthetic Joint Infection
Sendi, P., Rohrbach, M., Graber, P., Frei, R., Ochsner, P. E., & Zimmerli, W. (2006) · Clinical Infectious Diseases · doi:10.1086/507633 · Cited by 232
Evolutionary causes and consequences of bacterial antibiotic persistence
Bakkeren, E., Diard, M., & Hardt, W.-D. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0378-z · Cited by 224
Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections
Tuchscherr, L., Bischoff, M., Lattar, S. M., Noto Llana, M., Pförtner, H., Niemann, S., Geraci, J., Van de Vyver, H., Fraunholz, M. J., Cheung, A. L., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004870 · Cited by 211
Self-citationGao, W., Chua, K., Davies, J. K., Newton, H. J., Seemann, T., Harrison, P. F., Holmes, N. E., Rhee, H.-W., Hong, J.-I., Hartland, E. L., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000944 · Cited by 218
Iron acquisition strategies of bacterial pathogens
Sheldon, J. R., Laakso, H. A., & Heinrichs, D. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0010-2015 · Cited by 219
Inside job: Staphylococcus aureus host-pathogen interactions
Horn, J., Stelzner, K., Rudel, T., & Fraunholz, M. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2017.11.009 · Cited by 206
Foreign body infections due to Staphylococcus epidermidis
Uçkay, I., Pittet, D., Vaudaux, P., Sax, H., Lew, D., & Waldvogel, F. (2009) · Annals of Medicine · doi:10.1080/07853890802337045 · Cited by 203
Tavares, M., Kozak, M., Balola, A., & Sá-Correia, I. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00139-19 · Cited by 184
Qin, L., Yang, S., Zhao, C., Yang, J., Li, F., Xu, Z., Yang, Y., Zhou, H., Li, K., Xiong, C., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00332-w · Cited by 190
“60 64 Salmonella species, Brucella species, and Neisseria gonorrhoeae can mediate the persistence and recurrence of infections through the formation of SCVs. 32 Rare pathogens in speci fi c environments or populations can also cause osteomyelitis.”
BackgroundPseudomonas aeruginosa virulence and therapy: Evolving translational strategies*
Veesenmeyer, J. L., Hauser, A. R., Lisboa, T., & Rello, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ff137 · Cited by 196
Geisinger, E., & Isberg, R. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw402 · Cited by 197
Exit from dormancy in microbial organisms
Dworkin, J., & Shah, I. M. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2453 · Cited by 192
“Examples include slow-growing small-colony variants of Staphylococcus aureus and of several phylogenetically diverse specie”
BackgroundChronic Implant-Related Bone Infections—Can Immune Modulation be a Therapeutic Strategy?
Seebach, E., & Kubatzky, K. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01724 · Cited by 198
“SCVs are a metabolically inactive and slow-growing form of bacteria that forms due to defects in electron transport and thymidine biosynthesis (49).”
BackgroundWolter, D. J., Emerson, J. C., McNamara, S., Buccat, A. M., Qin, X., Cochrane, E., Houston, L. S., Rogers, G. B., Marsh, P., Prehar, K., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit270 · Cited by 190
Novel Insights into Staphylococcus aureus Deep Bone Infections: the Involvement of Osteocytes
Yang, D., Wijenayaka, A. R., Solomon, L. B., Pederson, S. M., Findlay, D. M., Kidd, S. P., & Atkins, G. J. (2018) · mBio · doi:10.1128/mbio.00415-18 · Cited by 179
Dunyach-Remy, C., Ngba Essebe, C., Sotto, A., & Lavigne, J.-P. (2016) · Toxins · doi:10.3390/toxins8070209 · Cited by 168
Biswas, L., Biswas, R., Schlag, M., Bertram, R., & Götz, F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01211-09 · Cited by 182
Roles of Two-Component Regulatory Systems in Antibiotic Resistance
Tierney, A. R., & Rather, P. N. (2019) · Future Microbiology · doi:10.2217/fmb-2019-0002 · Cited by 171
“Furthermore and finally, small colony variants [269] in this species are known to have increased biofilm production and multidrug resistance [270], and interestingly, a recent study on clinical isolates of P.”
BackgroundGarcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Self-citationActivation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens
Werth, N., Beerlage, C., Rosenberger, C., Yazdi, A. S., Edelmann, M., Amr, A., Bernhardt, W., von Eiff, C., Becker, K., Schäfer, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011576 · Cited by 173
Self-citationIdelevich, E. A., Schüle, I., Grünastel, B., Wüllenweber, J., Peters, G., & Becker, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12640 · Cited by 164
“isolates displaying the small colony variant phenotype [23], would need more time to be identified by MALDI-TOF MS.”
BackgroundSelf-citationMechanisms of Antibiotic Failure During Staphylococcus aureus Osteomyelitis
Gimza, B. D., & Cassat, J. E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638085 · Cited by 158
“Given that bactericidal antibiotics target active cellular processes, a decrease in growth rate can result in increased tolerance to these antibiotics (41, 47).”
BackgroundMuthukrishnan, G., Masters, E. A., Daiss, J. L., & Schwarz, E. M. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00548-4 · Cited by 158
Staphylococcus aureus persistence in non-professional phagocytes
Löffler, B., Tuchscherr, L. P. N., Niemann, S., & Peters, G. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.011 · Cited by 167
“Currently, it is nknown if these dynamically forming SCVs feature similar characeristics as stable SCV-mutants, such as increased resistance against ntibiotics and oxidative stress.”
BackgroundSelf-citationBesier, S., Smaczny, C., von Mallinckrodt, C., Krahl, A., Ackermann, H., Brade, V., & Wichelhaus, T. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01510-06 · Cited by 164
Mitchell, G., Séguin, D. L., Asselin, A.-E., Déziel, E., Cantin, A. M., Frost, E. H., Michaud, S., & Malouin, F. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-33 · Cited by 165
The Staphylococcus aureus RNome and Its Commitment to Virulence
Felden, B., Vandenesch, F., Bouloc, P., & Romby, P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002006 · Cited by 160
In vitro antimicrobial susceptibility testing methods: agar dilution to 3D tissue-engineered models
Schumacher, A., Vranken, T., Malhotra, A., Arts, J. J. C., & Habibović, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3089-2 · Cited by 160
Ayon, N. J. (2023) · Metabolites · doi:10.3390/metabo13050625 · Cited by 183
Vulin, C., Leimer, N., Huemer, M., Ackermann, M., & Zinkernagel, A. S. (2018) · Nature Communications · doi:10.1038/s41467-018-06527-0 · Cited by 167
Hammer, N. D., Reniere, M. L., Cassat, J. E., Zhang, Y., Hirsch, A. O., Indriati Hood, M., & Skaar, E. P. (2013) · mBio · doi:10.1128/mbio.00241-13 · Cited by 155
Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics
Lechner, S., Lewis, K., & Bertram, R. (2012) · Microbial Physiology · doi:10.1159/000342449 · Cited by 155
Tuchscherr, L. P. N., Löffler, B., & Proctor, R. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01028 · Cited by 167
Self-citationPainter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
Long, S. W., Olsen, R. J., Mehta, S. C., Palzkill, T. G., Cernoch, P. L., Perez, K. K., Musick, W. L., Rosato, A. E., & Musser, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03622-14 · Cited by 161
Shettigar, K. S., & Murali, T. S. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03984-8 · Cited by 176
Metadata
- Authors
- Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G.
- Affiliations
- University of Wisconsin–Madison (US)
- University of Münster (DE)
- Universitätsklinikum des Saarlandes (DE)
- Corresponding author
- Proctor, Richard A.
- Venue
- Nature Reviews Microbiology
- Published
- 2006-04
- Volume
- 4
- Issue
- 4
- Pages
- 295-305
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W2088960594
- Cited by
- 1,175
- References
- 116
- Citations by year
- 2026: 40 · 2025: 54 · 2024: 52 · 2023: 57 · 2022: 75 · 2021: 71 · 2020: 78 · 2019: 89 · 2018: 61 · 2017: 63 · 2016: 68 · 2015: 67 · 2014: 67 · 2013: 75 · 2012: 56
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- small colony variants, Staphylococcus aureus, metabolic deficiency, antibiotic resistance, persistent infection, recurrent infections, latent infection, bacterial identification, Staphylococcus
- MeSH terms
- Aminoglycosides, Animals, Bacteria, Bacterial Infections, Humans, Phenotype, Staphylococcus aureus, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.